Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma

被引:0
作者
Lili Wang
Junliang Lu
Huanwen Wu
Li Wang
Xiaolong Liang
Zhiyong Liang
Tonghua Liu
机构
[1] Peking Union Medical College Hospital,Molecular Pathology Research Center, Department of Pathology
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,undefined
来源
Diagnostic Pathology | / 12卷
关键词
Pancreatic ductal adenocarcinoma; GAB; CRKL; FRS2; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 142 条
[1]  
Pettazzoni P(2015)Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer Cancer Res 75 1091-1101
[2]  
Viale A(2015)Targeting RTK Signaling Pathways in Cancer Cancers 7 1758-1784
[3]  
Shah P(1997)Signaling through scaffold, anchoring, and adaptor proteins Science 278 2075-2080
[4]  
Carugo A(2008)Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins Cancer Sci 99 1319-1325
[5]  
Ying H(2008)Amplification of 11q13 in ovarian carcinoma Genes Chromosomes Cancer 47 481-489
[6]  
Wang H(2015)The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer Mol Cancer Res 13 502-509
[7]  
Genovese G(2010)Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer Oncogene 29 1421-1430
[8]  
Seth S(2011)Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers Cancer Discov 1 608-625
[9]  
Minelli R(2014)In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogene Proc Natl Acad Sci U S A 111 1102-1107
[10]  
Green T(2015)Oncogenic Signaling Adaptor Proteins J Genet Genomics 42 521-529